Status
Conditions
Treatments
About
This prospective registry is intended to evaluate the safety and efficacy of the Optimax® stent.
Full description
This prospective registry is intended to evaluate the safety and efficacy of the Optimax® stent in de novo coronary lesions with reference diameter ≥ 3.0 mm and Length ≤ 20 mm.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
350 participants in 1 patient group
Loading...
Central trial contact
Fundación EPIC
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal